703797007: Ponatinib hydrochloride (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Transferase inhibitor\Phosphotransferase inhibitor\Protein kinase inhibitor\Protein-tyrosine kinase inhibitor\Ponatinib hydrochloride (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substance with benzamide structure\Ponatinib hydrochloride (substance)

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substance with benzamide structure\Ponatinib hydrochloride (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2014. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3009699010 Ponatinib hydrochloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3009817013 Ponatinib hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

21301000188111 ponatinib chlorhydrate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

834671000172110 chlorhydrate de ponatinib fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Ponatinib hydrochloride (substance)	Is a	Ponatinib	false	Inferred relationship	Some
Ponatinib hydrochloride (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Protein-tyrosine kinase inhibitor (disposition)	true	Inferred relationship	Some
Ponatinib hydrochloride (substance)	Is a	produit chimique catégorisé selon sa fonction	false	Inferred relationship	Some
Ponatinib hydrochloride (substance)	Is a	Enzyme inhibitor	false	Inferred relationship	Some
Ponatinib hydrochloride (substance)	Is a	Benzamide (substance)	false	Inferred relationship	Some
Ponatinib hydrochloride (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Ponatinib	true	Inferred relationship	Some
Ponatinib hydrochloride (substance)	Is a	Protein-tyrosine kinase inhibitor	true	Inferred relationship	Some
Ponatinib hydrochloride (substance)	Is a	Substance with benzamide structure	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely ponatinib (as ponatinib hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ponatinib hydrochloride (substance)	Inferred relationship	Some
Ponatinib (as ponatinib hydrochloride) 45 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ponatinib hydrochloride (substance)	Inferred relationship	Some
Product containing precisely ponatinib (as ponatinib hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ponatinib hydrochloride (substance)	Inferred relationship	Some	1
Ponatinib (as ponatinib hydrochloride) 45 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ponatinib hydrochloride (substance)	Inferred relationship	Some	1
Product containing precisely ponatinib (as ponatinib hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ponatinib hydrochloride (substance)	Inferred relationship	Some	1
Ponatinib (as ponatinib hydrochloride) 45 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ponatinib hydrochloride (substance)	Inferred relationship	Some	1
Product containing precisely ponatinib (as ponatinib hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ponatinib hydrochloride (substance)	Inferred relationship	Some	1

This concept is not in any reference sets